Publication | Closed Access

Concordance between results of somatostatin receptor scintigraphy with 111In-DOTA-DPhe1-Tyr3-octreotide and chromogranin A assay in patients with neuroendocrine tumours

Neuroendocrine TumoursSomatostatin Receptor ScintigraphyMedicineNeuroendocrine DisorderPathologyAdrenal DiseaseNeuroendocrine TumorsEndocrinologyOncologyRadiation OncologyNuclear MedicineCancer ResearchEndocrine-related Cancer